Effectiveness of Behavioral Highway Safety Countermeasures

Effectiveness of Behavioral Highway Safety Countermeasures

Author: David F. Preusser

Publisher: Transportation Research Board

ISBN: 9780309117548

Category: Traffic safety

Page: 60

View: 848

TRB¿s National Cooperative Highway Research Program (NCHRP) Report 622: Effectiveness of Behavioral Highway Safety Countermeasures explores a framework and guidance for estimating the costs and benefits of emerging, experimental, untried, or unproven behavioral highway safety countermeasures.

Traffic Safety and Human Behavior

Traffic Safety and Human Behavior

Author: David Shinar

Publisher: Emerald Group Publishing

ISBN: 9781786352217

Category: Transportation

Page: 1264

View: 252

This comprehensive 2nd edition covers the key issues that relate human behavior to traffic safety. In particular it covers the increasing roles that pedestrians and cyclists have in the traffic system; the role of infotainment in driver distraction; and the increasing role of driver assistance systems in changing the driver-vehicle interaction.

Drugs, Driving and Traffic Safety

Drugs, Driving and Traffic Safety

Author: Joris C. Verster

Publisher: Springer Science & Business Media

ISBN: 9783764399238

Category: Medical

Page: 559

View: 605

Drugs, Driving and Traffic Safety gives a comprehensive overview of the effects of different medical conditions like neurological disorders, anxiety and depression and their pharmaceutical treatment on driving ability. In addition, the effects of alcohol and drugs of abuse are discussed. Leading experts present the different methodologies to examine effects of drugs on driving, and summarize the recent scientific evidence including epidemiological studies, roadside surveys, laboratory tests, driving simulators, and the standardized driving test. The volume includes guidelines of the International Council on Alcohol, Drugs and Traffic Safety (ICADTS) and the ICADTS Drugs List 2007. Drugs, Driving and Traffic Safety is written for physicians, psychiatrists and pharmacists who want to inform their patients who use psychoactive drugs.